Newsletter

Winter 2025 Newsletter 

The Patient And family member Reactions to biomarker-informed ADRD DiagnosEs (PARADE) research study is examining how individuals and their family members respond to learning the results of Alzheimer’s disease (AD) biomarker tests, such as PET brain scans, cerebrospinal fluid, and blood samples. Led by principal investigators Jennifer Lingler, PhD, CRNP, FAAN, from the University of Pittsburgh and Joshua Grill, PhD, from the University of California, Irvine, PARADE is the first large-scale initiative to characterize the full range of experiences of people receiving biomarker-informed Alzheimer’s disease and related dementias (ADRD) diagnoses.

The winter 2025 PARADE Newsletter will be mailed to participants enrolled in the study. The newsletter highlights site updates, a conference feature, and enrollment updates.

Read more in the Winter 2025 Newsletter below:

Study Enrollment Update

You can see from our map where participants live across the USA. We’ve interviewed people living in 16 different states from California to Massachusetts and Texas to Michigan.